Eiropas Savienība -
latviešu -
EMA (European Medicines Agency)
abiraterone mylan
mylan ireland limited - abiraterona acetāts - prostatas audzēji - endocrine therapy, other hormone antagonists and related agents - abiraterone mylan is indicated with prednisone or prednisolone for:the treatment of newly diagnosed high risk metastatic hormone sensitive prostate cancer (mhspc) in adult men in combination with androgen deprivation therapy (adt). the treatment of metastatic castration resistant prostate cancer (mcrpc) in adult men who are asymptomatic or mildly symptomatic after failure of androgen deprivation therapy in whom chemotherapy is not yet clinically indicated. the treatment of mcrpc in adult men whose disease has progressed on or after a docetaxel based chemotherapy regimen.
Eiropas Savienība -
latviešu -
EMA (European Medicines Agency)
abiraterone krka
krka, d.d., novo mesto - abiraterona acetāts - prostatas audzēji - endokrīnā terapija - abiraterone krka is indicated with prednisone or prednisolone for:the treatment of newly diagnosed high risk metastatic hormone sensitive prostate cancer (mhspc) in adult men in combination with androgen deprivation therapy (adt) (see section 5. 1)the treatment of metastatic castration resistant prostate cancer (mcrpc) in adult men who are asymptomatic or mildly symptomatic after failure of androgen deprivation therapy in whom chemotherapy is not yet clinically indicated (see section 5. 1)the treatment of mcrpc in adult men whose disease has progressed on or after a docetaxel-based chemotherapy regimen.
Eiropas Savienība -
latviešu -
EMA (European Medicines Agency)
abiraterone accord
accord healthcare s.l.u. - abiraterona acetāts - prostatas audzēji - endokrīnā terapija - abiraterone accord is indicated with prednisone or prednisolone for:the treatment of newly diagnosed high risk metastatic hormone sensitive prostate cancer (mhspc) in adult men in combination with androgen deprivation therapy (adt)the treatment of metastatic castration resistant prostate cancer (mcrpc) in adult men who are asymptomatic or mildly symptomatic after failure of androgen deprivation therapy in whom chemotherapy is not yet clinically indicatedthe treatment of mcrpc in adult men whose disease has progressed on or after a docetaxel based chemotherapy regimen.
Latvija -
latviešu -
Zāļu valsts aģentūra
diane-35 0,035 mg/2 mg apvalkotās tabletes
bayer ag, germany - ethinylestradiolum, cyproteroni acetas - apvalkotā tablete - 2000 mikrogramu/35 mikrogramu
Latvija -
latviešu -
Zāļu valsts aģentūra
diane-35 0,035 mg/2 mg apvalkotās tabletes
bayer ag, germany - ethinylestradiolum, cyproteroni acetas - apvalkotā tablete - 2000 mikrogramu/35 mikrogramu
Latvija -
latviešu -
Zāļu valsts aģentūra
diane-35 0,035 mg/2 mg apvalkotās tabletes
bayer ag, germany - ethinylestradiolum, cyproteroni acetas - apvalkotā tablete - 2000 mikrogramu/35 mikrogramu
Latvija -
latviešu -
Zāļu valsts aģentūra
diane-35 0,035 mg/2,0 mg apvalkotās tabletes
bayer pharma ag, germany - ethinylestradiolum, cyproteroni acetas - apvalkotā tablete - 35 mikrogramu/2000 mikrogramu
Latvija -
latviešu -
Zāļu valsts aģentūra
diane-35 apvalkotās tabletes
bayer pharma ag, germany - ethinylestradiolum, cyproteroni acetas - apvalkotās tabletes - 2000 micrograms/35 micrograms
Latvija -
latviešu -
Zāļu valsts aģentūra
diane 2000 mikrogramu/35 mikrogramu apvalkotās tabletes
bayer ag, germany - cyproteroni acetas, ethinylestradiolum - apvalkotā tablete - 2000 mikrogramu/35 mikrogramu
Latvija -
latviešu -
Zāļu valsts aģentūra
diane-35 0,035 mg/2 mg apvalkotās tabletes
bayer ag, germany - cyproteroni acetas, ethinylestradiolum - apvalkotā tablete - 2000 mikrogramu/35 mikrogramu